Mice overexpressing progastrin (PG) in intestinal mucosa (fatty acid-binding protein (Fabp)-PG mice) are at an increased risk of proximal colon carcinogenesis in response to azoxymethane. Here, we report a significant increase in the length of proximal colonic crypts in Fabp-PG mice, associated with potent antiapoptotic effects of PG, which likely contributed to the previously reported increase in colon carcinogenesis in Fabp-PG mice. Phosphorylation of kinase of IjBa (IKKa/b), inhibitor of jB (IjB)a and p65NF-jB was significantly elevated in proximal colonic crypts of Fabp-PG versus wild-type mice, which was associated with degradation of IjBa and nuclear translocation/activation of p65. Surprisingly, distal colonic crypt cells were not as responsive to elevated levels of PG in Fabp-PG mice. Annexin II, recently described as a high-affinity receptor for PG, strongly colocalized with PG intracellularly and on basolateral membranes of proximal crypt cells, providing evidence that annexin-II binds PG in situ in colonic crypt cells. Proliferative and antiapoptotic effects of PG on proximal crypts of Fabp-PG mice were attenuated to wild-type levels, on treatment with NEMO peptide (an inhibitor of nuclear factor-jB (NF-jB) activation), demonstrating for the first time a critical role of NF-jB in mediating hyperproliferative affects of PG on colonic crypts of Fabp-PG mice, in vivo. Thus, downregulation of NF-jB may significantly reduce the increased risk of colon carcinogenesis in response to PG.
Introduction
Processing intermediates of gastrin gene products, such as progastrin (PG) exert mitogenic effects in vitro and in vivo on intestinal mucosal cells (Seva et al., 1994; Wang et al., 1996; Baldwin et al., 2001; Ottewell et al., 2003 Ottewell et al., , 2005 Singh et al., 2003) . Potent antiapoptotic effects of recombinant human PG (rhPG) were also described on intestinal and pancreatic cancer cells in vitro (Wu et al., 2003; Rengifo-Cam et al., 2007) . Transgenic (Tg) mice overexpressing PG from either the liver (hGAS mice) or intestinal epithelial cells (fatty acid-binding protein, (Fabp)-PG mice) were at a higher risk for developing preneoplastic and neoplastic lesions in colons in response to azoxymethane (AOM) (Singh et al., 2000a, b; Cobb et al., 2004) ; treatment with G-Gly (glycine-extended gastrin) also increased the risk in rats (Aly et al., 2001) . Thus, non-amidated gastrins (PG and G-Gly) exert co-carcinogenic effects in vivo (reviewed in Rengifo-Cam and Singh, 2004) .
Under physiological conditions, only processed forms of gastrins (G 17 , G 34 ) are present in the circulation (as described in Dockray et al., 1996) . In patients with colorectal cancers and hypergastrinemia (due to various etiologies), elevated levels of circulating PG (0.1 to >1.0 nM) are measured (reviewed in Rengifo-Cam and Singh, 2004 ). As we reported co-carcinogenic effects of PG in Fabp-PG mice that express 'pathophysiological' concentrations of hPG (o1-5 nM) (Cobb et al., 2004) , it suggests that elevated levels of circulating PG, as measured in certain diseases, may be involved in colon carcinogenesis.
Co-carcinogenic effects of PG could be mediated by either proliferative and/or antiapoptotic effects on colonic epithelial cells. DNA-damaging agents trigger cell death in proliferative zone of colonic crypt cells (Marshman et al., 2001) . It is possible that mice expressing PG are resistant to apoptotic affect of AOM, which may contribute to the observed increase in colon carcinogenesis in PG expressing mice; this possibility was examined.
We previously reported a significant increase in preneoplastic and neoplastic lesions in proximal versus distal colons of PG expressing mice, in response to AOM (Singh et al., 2000b; Cobb et al., 2004) ; mechanisms mediating a differential response remain(s) unknown. One possibility is that proximal colons are more responsive to proliferative and/or antiapoptotic effects of PG compared to distal colons; this possibility was examined.
Monomeric/heterotetrameric annexin II (ANX-II) present on extracellular surface of endothelial and tumor cells, functions as high-affinity receptor for plasminogen, tissue plasminogen activator (tPA), plasmin (Hajjar et al., 1994) and extracellular matrix protein tenascin-C (Chung and Erickson, 1994) . ANX-II is also a high-affinity receptor for PG peptides, required for mediating growth effects of PG on intestinal epithelial, colon and pancreatic cancer cells in vitro (Rengifo-Cam et al., 2007; Singh et al., 2007) . Differential effects of PG on proximal versus distal colons could be due to differences in interaction of ANX-II with PG in the two parts of colon; this intriguing possibility was examined.
MAP kinases and nuclear factor-kB (NF-kB) are activated in a pancreatic cancer cell line, in vitro, in response to PG (Rengifo-Cam et al., 2007) . In the current studies we report for the first time a critical role of NF-kB activation in mediating proliferative and antiapoptotic effects of PG on colonic crypt cells in vivo. In addition, our studies provide novel insights into the mechanisms that may be contributing to differential effects of PG on proximal versus distal colonic crypts, which may be clinically relevant in understanding etiology of proximal versus distal colon carcinogenesis in humans.
Results

Length of colonic crypts
Crypt lengths in proximal (P) colons of Fabp-PG mice were significantly increased compared to that recorded in wild-type (WT) littermates, whereas crypt lengths in distal (D) colons of WT and Fabp-PG mice were similar ( Figure 1a) . Number of cells per crypt column in proximal colons of WT and Fabp-PG mice was B25 and 55-70 cells, respectively. Length of intact proximal colonic crypts was similarly increased by B40-50% in Fabp-PG versus WT mice, whereas length of intact distal colonic crypts was similar in WT versus Fabp-PG mice (Figures 1b and c) .
Proliferation and apoptotic indices of colonic crypts
Representative sections from proximal colons of WT versus Fabp-PG mice, stained for proliferating cell nuclear antigen (PCNA), are shown in Figure 2a . On the basis of number of cells labeled per longitudinal crypt, proliferation index (PI) was calculated, and data from 50 to 100 crypts per group of mice are presented in Figure 2b . PI was significantly increased in proximal colons of Fabp versus WT mice ( Figure 2b) ; PI from distal colons was similar in the two groups of mice (data not shown). A low basal rate of apoptosis (0.2-0.4 cells per crypt) was detected in WT and Fabp-PG mice injected with saline (data not shown), as previously reported (Lifshitz et al., 2001) . Possible protective effects of PG against AOM-induced apoptosis were examined. Representative sections from proximal colons of WT and Fabp-PG mice, stained with either hematoxylin and eosin (H&E) (Figure 2c ), terminal transferasemediated dUTP-biotin nick end labeling (TUNEL) assay (Figure 2e ) or activated-caspase3 antibodies (Figure 2g ) are shown. Using all three methods, AOM-induced apoptosis of proximal colonic crypts was significantly lower in Fabp-PG versus WT mice (Figures 2c-h ), whereas apoptotic index (AI) of distal colonic crypts was similar (data not shown). These results demonstrate the intriguing possibility that PG protects proximal colonic crypts from acute apoptotic effects of AOM on the proliferative zone.
Immunolocalization of PG and its receptor annexin-II in colonic crypts of WT and Fabp-PG mice Immunostaining for PG was not detected in distal (D) or proximal (P) colons of WT mice (Figure 3 ). In Fabp-PG mice, the entire longitudinal crypt axis stained positive for PG (Figure 3 ). Relative levels of gastrin cDNA, in distal and proximal colonic crypts of Fabp-PG mice, were similar when measured by quantitative RT-PCR (data not shown). PG was localized to colonic crypts and not detected in interstitial cells (Figure 3 ). Concurrently processed sections in which primary antibody was replaced with purified rabbit immunoglobulin G (IgG), failed to exhibit staining (data not shown). In WT mice, ANX-II staining was localized to basolateral and apical membranes of distal and proximal crypts (Figure 3) . Similarly, in distal crypts of Fabp-PG mice, intense basolateral and apical staining for ANX-II was detected (Figure 3 ). However, proximal crypts from Fabp-PG mice exhibited a dramatic increase in cytoplasmic staining with a gradient of increasing crypt base: surface immunoreactivity, similar to that recorded for PG, along with perinuclear staining and some hint of nuclear staining (Figure 3 ). Marked co-localization of ANX-II with PG was observed intracellularly and within the nucleus in proximal colons of Tg mice (Figure 3 ). However, PG and ANX-II co-localized only at basolateral, apical and junctional membranes of distal crypts from Fabp-PG mice (Figure 3) . PG, bound to ANX-II, was differentially retained in distal crypts of Tg mice (Figure 3 ; Supplementary Figure 1A) . The in situ binding of PG with ANX-II was confirmed by coimmunoprecipitation of PG with ANX-II from proximal and distal crypts of PG mice (Supplementary Figure 1B) . Relative levels of ANX-II in distal colonic crypts were B60-80% of that in proximal crypts (Supplementary Figure 1B) , which may be contributing to the observed loss in retention of PG in distal versus proximal crypts (Figure 3; Supplementary Figure 1 ). Figure 2A) . Nuclear extracts from distal crypts of Fabp-PG mice were positive for p-ERK1/2 (data not shown), but relative levels of nuclear p-ERK1/2 were significantly higher in proximal crypts of Fabp-PG versus WT mice (Supplementary Figure 2A) . The presence of p-ERK1/2 in nuclei of proximal crypt cells was confirmed immunohistochemically (Supplementary Figure 2B) . Cytoplasm, but not nuclei, from distal crypts of both WT and Fabp-PG mice were positive for p-ERK (Supplementary Figure  2B) . However, p-ERKs were predominantly present in nuclei of proximal crypts from Fabp-PG mice, compared to cytoplasmic and occasional nuclear staining in proximal crypts of WT mice (Supplementary Figure 2B) . We next examined if NF-kB is activated in vivo in Fabp-PG mice by the canonical pathway. Data from WBs (n ¼ 5 mice per group) were densitometrically analysed for each molecule, and presented as a ratio of p-IKKa/b:IKKa/b in Figure 4a . Relative levels of total inhibitor of kB kinases (IKKs) were similar in cellular extracts from proximal and distal crypts of WT mice, and assigned a 100% value (Figure 4a ). Ratio of phosphorylated versus total IKKa/b was manyfold higher in proximal crypts of Fabp-PG mice compared to all other groups (Figure 4a ).
Representative WB from one of the five mouse samples, for phosphorylated and total IkBa are presented in Figure 4b ; ratio of phosphorylated versus total IkBa from all samples are shown as bar graphs in Figure 4c . Relative levels of p-IkBa increased significantly in proximal versus distal crypts of Fabp-PG mice, whereas p-IkBa levels in distal and proximal colons of WT mice were similar. WB data were confirmed immunohistochemically, wherein the accumulation of p-IkBa was increased in proximal but not distal crypts Degradation of IkBa results in translocation of NFkB to nuclei. Representative WB data from one of the five mouse samples, demonstrating p-p65 and total p65 levels are presented in Figure 5a . NF-kBp65 levels were similar in distal and proximal crypts of WT mice; baseline levels of total p65 were elevated in distal and proximal crypts of Tg mice (Figure 5a ), suggesting possible increase in expression/stabilization of p65 in Tg versus WT mice. Transcriptional activity of NF-kB is controlled by phosphorylation at Serines 276, 529 and 536 (Hayden and Ghosh, 2004) . We found that relative levels of pp65
276
, but not pp65
536
, increased in cellular No staining for PG was detected in sections from WT mice. In the case of Fabp-PG (Tg) mice, in sections from distal colons, intense basolateral staining for ANX-II, which extended throughout the longitudinal crypt axis with minimal cytoplasmic staining was observed. However, crypts from proximal colons of Tg mice exhibited dramatic increase in cytoplasmic staining for ANX-II with a gradient of increasing crypt base: surface immunoreactivity, along with perinuclear and nuclear staining. Equivalent levels of gastrin gene were expressed in distal and proximal colons of Tg mice (as measured by quantitative real-time PCR). However, relatively low levels of PG were retained in distal colonic crypts of Tg mice, whereas significant levels were retained within the proximal colonic crypts of Tg mice. Merged images of PG and ANX-II staining, demonstrated co-localization of PG and ANX-II only at the basolateral and apical membranes in the distal colonic crypts of Tg mice, with no co-localization intracellularly, which essentially resembled the pattern of ANX-II staining observed in the distal colons of Tg mice. In few mice, higher levels of PG were retained in the distal colonic crypts (representative data are presented in Supplementary Figure 1A) . In spite of higher retention of PG in distal crypts of 10-20% of PG mice, PG, bound to ANX-II, remained co-localized at the apical and lateral membranes of the distal crypts (Supplementary Figure 1A) . The merged images of proximal colonic crypts from Tg mice, on the other hand, demonstrated marked co-localization of PG and ANX-II staining at both the apical/ lateral poles and within the cytoplasm and even nucleus (Figure 3 ). Arrows indicate co-localization of ANX-II and PG at plasma membranes; arrowheads indicate co-localization of ANX-II and PG intracellularly.
NFjB mediates growth effects of progastrin in vivo S Umar et al A significant increase in DNA binding of nuclear extracts from proximal versus distal crypts of Tg mice were measured ( Figure 5c ); no significant differences were measured in distal and proximal crypts of WT mice (Figure 5c ). Presence of both p50 and p65 was confirmed in DNA-binding assay using specific antibodies, suggesting that p50/p65 heterodimers are translocated to nucleus in proximal colons of Tg mice (data not shown). Immunohistochemistry (IHC) revealed presence of basal staining for pp65 276 in cytosol and nuclei of crypts from all 276 . The data demonstrate several fold increase in percentage cells positive for phosphorylated p65 in nuclei of proximal colons of Tg mice compared to that in distal colons (n ¼ 5).
NFjB mediates growth effects of progastrin in vivo S Umar et al
Activation of NF-kB is required for mediating proliferative and antiapoptotic effects of PG on proximal crypts. Fabp-PG mice were treated with either NEMO peptide, an inhibitor of IKKa/b, or control peptide. Treatment of Fabp-PG mice with NEMO did not result in loss of extracellular signal-regulated kinase (ERK) phosphorylation (Figure 6a ), but significantly inhibited phosphorylation of IKKa/b at Ser176/180 (Figure 6b ) and IkBa at Ser32/36 ( Figure 6c) ; this confirmed specific effect of NEMO on IKK signaling pathway. Loss of IkBa phosphorylation in proximal crypts (Figure 6c ) resulted in inhibition of NF-kB activity in a DNAbinding assay in samples from NEMO versus control peptide-treated mice ( Figure 6di) ; basal level of activation measured in NEMO-treated samples of proximal crypts was similar to that measured in corresponding control and NEMO-treated distal crypts (upper and lower panels of Figure 6di ).
Loss in NF-kB activation, correlated with a loss in relative levels of p-p65 276 in nuclei of proximal crypts, measured biochemically ( Figure 6dii ) and by IHC (Figure 6diii ). NF-kB inhibition in vivo was associated with a significant loss in number of 5 0 -bromo-deoxyuridine (BrdU)-positive cells in proximal crypts of NEMO-treated Fabp-PG mice (Figure 6ei ), leading to decrease in PI of proximal colons (Figure 6eii ), compared to that in control peptide-treated samples. This led to a significant loss in antiapoptotic effects of PG on proximal crypt cells, as evidenced by a two-to threefold increase in relative levels of activated-caspase3 in NEMO-versus control peptide-treated samples (Figure 6f ). These results suggest, for the first time, a critical role for NF-kB in mediating proliferative and antiapoptotic effects of PG on proximal colonic crypts in vivo. Relative levels of activated NF-kB in proximal colons of NEMO-treated Fabp-PG mice were reverted to levels measured in proximal colons of WT mice (Figure 5c ).
Discussion
We previously reported significant increase in proximal colon carcinogenesis in transgenic (Tg) mice overexpressing PG, in response to AOM (Singh et al., 2000a, b; Cobb et al., 2004) . Our current results suggest that both an increase in proliferation and decrease in AOMinduced apoptosis may contribute to the increase in proximal colon carcinogenesis in Tg mice. An increase in crypt cell proliferation from distal to proximal colons has been noted in normal human colons and in patients positive for sporadic colon cancers (Mills et al., 2001) ; it remains to be seen if the reported difference in humans are perhaps due to differential effects of growth factors (such as PG).
Mechanism(s) mediating differences in cancer cell biology of proximal versus distal colons are unknown. Proximal and distal colons are embryonically derived from midgut and hindgut, respectively (Johnson and McCormack, 1994) . Stem cells are located at the base in distal colons and toward the middle in proximal colons Figure 6 Effect of NEMO peptide on the levels of phosphorylated extracellular signal-regulated kinase (ERKs), kinase of IkBa (IKK)a/b, IkBa (a-c), p65NF-kB (di-iii), proliferation (ei-ii) and apoptosis (f) in colonic crypts. Mice were divided into two groups and injected, once a day for 4 days with either NEMO or control peptide (as described in 'Materials and methods'). At 2 h after the last injection, colonic crypts were isolated and fractionated into cellular and nuclear extracts. Data obtained from proximal colonic crypts of Fabp-progastrin (PG) Representative western blot of cellular extracts from one of four mice per group is presented. Treatment of Fabp-PG mice with NEMO peptide resulted in a significant increase in the relative levels of activated (A) caspase 3, with a concomitant decrease in relative levels of pro-caspase 3, in proximal colonic crypts when compared to that in mice treated with the control peptide. b-Actin was used as loading control. The relative levels of phosphorylated kinases, PI and activated caspase 3 in distal crypts of Fabp-PG mice was not significantly altered in NEMO-versus control-treated mice (data not shown), as these levels were not changed significantly in response to PG as presented in Figures 1, 2, 4 , and 5. Similarly, the relative levels of phosphorylation of the indicated kinases, PI and activated caspase 3 were not altered significantly in NEMO-versus control peptide-treated wild-type (WT) mice (data not shown), suggesting that IKKa/b/NF-kB pathway is not significantly involved in the basal growth of colonic crypts in the WT mice as suggested by the data presented in Figures 1, 2, 4 , and 5. (Sato and Ahnen, 1992) . Proximal and distal colorectal carcinomas (CRCs) exhibit differences in incidence in relation to geographic region, age, gender and hereditary cancer syndromes, suggesting two categories of CRC based on site and origin in the colon (Iacopetta, 2002) . Differences in expression of adenosine receptor subtypes, and response to adenosine, were reported in proximal versus distal colons of mice (Zizzo et al., 2006) . Methylation mediated silencing of mismatched repaired genes are significantly higher in proximal versus distal sporadic microsatellite instability CRCs (Watanabe et al., 2006) . Significant differences in expression of Bak (Liu et al., 1999) and cErbB2 (Fric et al., 2000) are present in right and left colons. Significant differences were reported in gene expression profiles of right versus left colons during embryonic development, which were amplified during post-natal development, which may explain differences in susceptibility of proximal versus distal colons to specific pathways of tumorigenesis (Glebov et al., 2003) . Thus differences in origin, biology and genetic expression profiles, may have contributed to the observed differences in proliferative and survival effects of PG on proximal versus distal colons of Fabp-PG mice.
We recently reported activation of NF-kB in pancreatic cancer cells in response to PG in vitro (RengifoCam et al., 2007) . Our current studies demonstrate for the first time, that NF-kB is activated differentially in proximal versus distal colons of Fabp-PG mice. Our studies demonstrate that PG upregulates phosphorylation of IKKa/b, resulting in degradation of IkBa and nuclear translocation/activation of phosphorylated NF-kBp65 in proximal, but not distal, crypts of Tg mice; differences in activation of NF-kB pathway, may contribute to differences in PI and length of proximal versus distal crypts in Tg mice.
Multiple signaling pathways lead to phosphorylation and activation of IKK complexes (Hayden and Ghosh, 2004) . MAPKs/ERKs were required for activating NF-kB in response to PG, in vitro (Rengifo-Cam et al., 2007 ). In the current study, we measured a significant increase in phosphorylation/activation of ERKs in proximal, but not distal, crypts of Tg mice, which may explain significant difference in activation of NF-kB in proximal versus distal crypts of Tg mice. Perhaps the most important finding was that NF-kB activation was required for mediating proliferative/antiapoptotic effects of PG on proximal crypt cells (Figure 6 ).
Several receptor subtypes mediate biological effects of gastrin/PG peptides (reviewed in Rengifo-Cam and Singh, 2004) . Growth factor effects of PG and G-Gly peptides are mediated by novel receptor mechanisms, distinct from CCK 2 R and CCK 1 R (Seva et al., 1994; Ahmed et al., 2005; Rengifo-Cam et al., 2007) . Earlier, we had identified a 33-36 kDa protein as a high-affinity binding protein for PG/gastrin peptides, which was pharmacologically different from CCK 1 R and CCK 2 R (Chicone et al., 1989) . Recently we discovered that ANX-II represented the novel p36 receptor protein . Unlike CCK 2 R-Abs, ANX-II-Abs completely attenuated growth effects of PG on AR42J cells and IEC cells in vitro (Rengifo-Cam et al., 2007; Singh et al., 2007) , and ANX-II expression was required for measuring growth effects of autocrine PG in a human colon cancer cell line . Studies to date have reported only growth promoting and antiapoptotic effects of nonamidated gastrins (reviewed in Rengifo-Cam and Singh, 2004) . G 17 , either stimulates (Song et al., 2003) or inhibits (Mu¨erko¨ster et al., 2005) growth of target cells by CCK 2 R, which may reflect relative expression of CCK 2 R versus annexin II on target cells, as recently reviewed (Singh, 2007) .
In the current studies we report for the first time in situ co-localization of ANX-II with PG in colonic crypts of Fabp-PG mice. A novel and surprising finding was that co-localization of ANX-II with PG was significantly different in proximal versus distal crypts of Fabp-PG mice. Although ANX-II strongly co-localized with PG intracellularly in proximal crypts, in distal crypts, ANX-II co-localized with PG only near basolateral and apical membranes of Fabp-PG mice. As expected, PG was not detected in crypts of WT mice, and ANX-II was largely present along basolateral and apical membranes of both proximal and distal crypts of WT mice, similar to the pattern observed in distal crypts of Fabp-PG mice. These results suggest the novel possibility that in the presence of PG, ANX-II becomes internalized in proximal, but not distal, crypts of PG mice. In preliminary studies, we have similarly reported intracellular co-localization of PG with ANX-II in intestinal epithelial cells in response to PG .
On the basis of our studies so far, it appears that ANX-II is required for mediating biological effects of PG on target cells. Similarly, tPA which functions as a protease and a cytokine, strongly co-localized with EGFR and ANX-II in pancreatic cancer cells (OrtizZapater et al., 2007) , and the authors concluded that tPA enhances growth of pancreatic cancer cells by interacting with EGFR and ANX-II. Binding of ligands with ANX-II results in activation of several signaling pathways, including NF-kB, JAK/STAT, p38 MAPK and MEKK4 (MAPK/ERK kinase kinase) (reviewed in Singh, 2007) . It is possible that internalization and colocalization of ANX-II with PG in proximal but not distal colonic crypts of Fabp-PG mice, provides the required platform for activation of several kinases resulting in the observed activation of Src, PI3K/Akt, JAK 2, STAT 5/3, ERKs, p38 MAPK and NF-kB, in response to PG in various target cells (Ferrand et al., 2005; Rengifo-Cam et al., 2007) , as diagrammatically presented in a review article (Singh, 2007) .
In summary, we demonstrate for the first time that PG significantly reduces apoptotic effects of AOM, in vivo, on the proliferative zone of proximal colonic crypt cells. The dual effect of increasing proliferation and decreasing AOM-induced apoptosis, may have resulted in the previously reported increase in proximal colon carcinogenesis in response to AOM in Fabp-PG mice (Cobb et al., 2004) . In addition, in the current studies we demonstrate for the first time that NF-kB is activated in vivo in response to PG in proximal colonic crypt cells of Fabp-PG mice, and that activation of NF-kB is critically required for mediating proliferative and antiapoptotic effects of PG on proximal crypt cells. Significant differences in intracellular localization of annexin II, bound to PG, in proximal versus distal colonic crypts may provide the underlying mechanism for the differential activation of growth promoting/ antiapoptotic signaling pathways, resulting in the observed differences in length of proximal versus distal colonic crypts in Tg mice. Innate differences in biology of proximal versus distal colonic crypts, resulting in differential retention of PG, bound to ANX-II, in proximal versus distal crypts, may be an additional contributing factor, which needs to be further examined.
Materials and methods
Housing of Fabp-PG mice
Fabp-PG mice were generated as described (Cobb et al., 2004) . Fatty acid-binding protein Fabp promoter was used to drive expression of human gastrin cDNA in small and large intestines. Fabp-PG mice and their WT littermates were bred and housed in animal housing facility at UTMB, using protocols approved by Institutional Animal Care and Use Committee at UTMB, as described (Cobb et al., 2004) . Only homozygous Fabp-PG mice (Tg/Tg) were used and confirmed by semiquantitative cycle PCR as described (Cobb et al., 2004) . Fabp-PG mice were positive for 0.5-2.0 nM PG in the plasma, whereas WT mice were negative (Cobb et al., 2004) . Circulating levels of amidated gastrins (G17) were similar in Fabp-PG and WT mice (B30 pM).
Treatment of mice with NEMO peptide
Peptides corresponding to NEMO-binding domain (NBD) of IKKa or IKKb specifically inhibit the induction of NF-kB activation without inhibiting basal NF-kB activity (May et al., 2000) . Therefore, to understand role of induced activation of NF-kB in mediating proliferative/antiapoptotic effects of PG in Fabp-PG mice, we treated mice with either wtNBD (NEMO peptide) or a control peptide (Imgenex, San Diego, CA, USA), as described (Dasgupta et al., 2004) . Peptides were solubilized in saline and mice injected i.p. with 1.25 mg per kg body weight, once daily for 4 days. The last injection was given 2 h before killing.
Isolation of colonic crypts
Intact colonic crypts were isolated from mice, as previously described (Umar et al., 2003) . Crypts were imaged on an inverted microscope with a 12-bit gray level charge-coupled device camera. Images were taken at Â 200 magnification and crypt length measured, using a standard microscale etched onto a glass slide using Metamorph image analysis software (Universal Imaging Corp., Brandywine Parkway, PA, USA). A total of B150 crypts per group were used for length measurements.
PCNA and BrdU staining of colonic crypts as a measure of proliferative index Proliferating cells were identified immunohistochemically by staining colonic sections for PCNA, as previously described (Umar et al., 2000) . The percentage of dark-stained cells per longitudinally oriented crypt was calculated as the PI. Ten well-oriented crypts were counted distally and proximally per animal. In a few experiments, mice were injected i.p. with BrdU (Roche Diagnostics, Germany) (160 mg per kg body weight) 2 h before death to label S-phase cells. Frozen sections from proximal and distal colons were processed for BrdU staining as previously described (Singh et al., 2000b) .
Histological and immunocytochemical analysis of colonic crypts for measuring markers of apoptotic death AOM (Sigma-Aldrich, St Louis, MO, USA) induces G to A point mutations in colonic cells, resulting in apoptosis (Hong et al., 1999) . Mice were injected i.p. with AOM (20 mg/kg body weight) (Singh et al., 2000b) and killed after 24 h. Colons were collected and fixed flat on Whatman filter paper in 10% formalin as described (Singh et al., 2000b; Cobb et al., 2004) , and processed by standard histological techniques. Sections (4 mm) stained with H&E were scored for apoptotic bodies. A duplicate set of colonic sections was subjected to TUNEL staining using in situ cell death detection kit (Roche Diagnostics). Total number of apoptotic cells within 10 welloriented longitudinal crypts from distal and proximal colons of each mouse were counted (five mice per group). AI was calculated as percentage apoptotic cells per crypt.
Caspases are activated in colonic crypt cells in proliferative zone in response to 1,2-dimethylhydrazine (Lifshitz et al., 2001) . We processed colonic sections for IHC with anti-active caspase-3 antibody. Slides were deparaffinized and incubated in methanol with 3% H 2 O 2 for 15 min, and rinsed with phosphate-buffered saline (PBS). Horse blocking serum was added for 20 min, and slides incubated overnight with anticaspase-3 antibody at 1:400 dilution (R&D Systems, Minneapolis, MN, USA), and with biotinylated secondary anti-rabbit antibody (1:200 dilution), followed by avidin-peroxidase reagent (Vectastain Elite ABC kit, Vector Laboratories Inc., Burlingame, CA, USA), and 3,3 0 -diaminobenzidine tetrahydrochloride (DAB). Control slides were treated with nonimmune IgG. Slides were viewed at Â 40 magnification with bright field microscopy, and number of stained cells within the crypts per field of view (usually about seven crypts) were recorded. Fifteen fields of view were examined for each mouse sample (five mice per group).
Western immunoblot analysis
Intact colonic crypts pelleted from proximal/distal colons were homogenized in lysis buffer, and cellular and nuclear extracts prepared as previously described (Wang et al., 2006; 
